Profiel
Adel Nada is the founder of FytonBio, GentiBio, Inc. Current jobs include Independent Director at Alia Therapeutics Srl since 2023.
Former job includes Vice President-Immunotherapy at Caladrius Biosciences, Inc. Education includes a graduate degree from Rush University and a doctorate from Alexandria University.
Actieve functies van Adel Nada
| Bedrijven | Functie | Begin |
|---|---|---|
Alia Therapeutics Srl
Alia Therapeutics Srl BiotechnologyHealth Technology Develops treatment of genetic diseases with genomic editing technology | Directeur/Bestuurslid | 09-05-2023 |
Eerdere bekende functies van Adel Nada
| Bedrijven | Functie | Einde |
|---|---|---|
GentiBio, Inc.
GentiBio, Inc. BiotechnologyHealth Technology Develops regulatory T-cells for allergic diseases | Algemeen Directeur | - |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Corporate Officer/Principal | - |
Opleiding van Adel Nada
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Rush University
Rush University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alexandria University
Alexandria University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
Alia Therapeutics Srl
Alia Therapeutics Srl BiotechnologyHealth Technology Develops treatment of genetic diseases with genomic editing technology | Health Technology |
GentiBio, Inc.
GentiBio, Inc. BiotechnologyHealth Technology Develops regulatory T-cells for allergic diseases | Health Technology |
















